Compare Aurora Cannabis Inc (ACB) vs Cloudflare Inc (NET) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

NET trades at $268.77, up 11% today after Scotiabank upgraded the stock citing AI growth potential. The stock shows strong bullish momentum with a consensus analyst rating of 'Buy' (70% of 40 analysts) and a price target of $246.58. Recent earnings beats and revenue growth to $2.17B in 2025 highlight operational strength, though negative net margins and high valuations (P/S 37.22) pose challenges. Technical indicators signal bullish trends with resistance near $262.

Outlook: Growth driven by AI infrastructure demand and strategic partnerships offers upside, but high valuation and lack of profitability increase risk. Investors should weigh robust revenue growth against margin pressures and competitive threats in the cloud sector.